The United States FDA has issued an emergency authorization of anti-malaria drug Hydroxychloroquine to be prescribed to COVID-19 patients. Previously the drugs prescription to treat COVID-19 was considered “off-label” use.

BREAKING: The United States FDA has issued an emergency authorization of anti-malaria drug Hydroxychloroquine to be prescribed to COVID-19 patients.

Previously the drugs prescription to treat COVID-19 was considered “off-label” use. pic.twitter.com/jkqGOlpahX

— Michael Coudrey (@MichaelCoudrey) March 30, 2020